Why is NeuroPace, Inc. (NPCE) up today (+1.98%)?
Educational Guide:Analyst Ratings & Target Valuation Guide →
Diplyzer AI Agent• NPCE AI Analysis
NPCE
NASDAQHealthcareNeuroPace, Inc.
$14.41
+0.28 (+1.98%)• Rating: D+
Day Range
14.12 - 14.55
52W Range
8.88 - 19.60
Market Cap
$0.49B
Volume
0.13M
NeuroPace, Inc. (NPCE) completed a Short Line Candle pattern on 25 Aug 2026 trading at $14.41 (+1.98% last session, +5.6% over 1M). Overall financial health rating sits at D+.
Key AI Agent Insights
- Financial Health: NeuroPace, Inc. reported a P/E ratio of -22.1 and ROE of 0.0% in its quarterly Q2 financial report dated 30 Jun 2026.(Learn about Financial Ratios & Health →)
- Analyst Consensus: Wall Street analysts maintain a Buy consensus rating on NeuroPace, Inc. Most recently, HC Wainwright & Co. maintained its rating to Buy on 29 Jul 2026.(Learn about Analyst Ratings →)
- Insider Activity: Corporate insiders recorded 8 purchases and 2 sales in NPCE, with the latest Form 4 filing executed on 27 Aug 2026.(Learn about Insider Trading & Disclosures →)
- News Sentiment: Financial news coverage for NPCE skews bullish with 58% positive sentiment across 10 tracked articles.(Learn about News & Market Sentiment →)
- Technical Pattern Setup: NeuroPace, Inc. chart analysis shows a Short Line Candle pattern detected on 25 Aug 2026, establishing a Neutral technical bias.(Learn about Technical Chart Patterns →)